Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Replimune Group (REPL) and Hookipa Pharma (HOOK)
HOOKIPA Pharma Analyst Ratings
JMP Securities Maintains Market Outperform on HOOKIPA Pharma, Raises Price Target to $24
Buy Rating and Price Target Increase for Hookipa Pharma Amid Clinical and Financial Progress
HOOKIPA Pharma Analyst Ratings
JMP Securities Maintains HOOKIPA Pharma(HOOK.US) With Buy Rating, Cuts Target Price to $23
Optimistic Outlook for Hookipa Pharma's Oncology Pipeline Prompts Buy Rating
HOOKIPA Pharma Analyst Ratings
Buy Rating Affirmed for Hookipa Pharma Amid Positive HB-200 Vaccine Trials and Robust Financial Position
HOOKIPA Pharma Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Hookipa Pharma (HOOK), Chemed (CHE)
Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), RAPT Therapeutics (RAPT) and Hookipa Pharma (HOOK)
RBC Capital Initiates a Buy Rating on Hookipa Pharma (HOOK)
Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK) and Femasys (FEMY)
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), BioMarin Pharmaceutical (BMRN) and Hookipa Pharma (HOOK)
HOOKIPA Pharma Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK), Praxis Precision Medicines (PRAX) and Blueprint Medicines (BPMC)
Buy Rating Affirmed for Hookipa Pharma Amidst Promising Pipeline and Strategic Advancements
Optimistic Buy Rating for Hookipa Pharma Based on Promising HB-200 Trial Results and Strategic Trial Design
Analysts Offer Insights on Healthcare Companies: Rockwell Med (RMTI), Hookipa Pharma (HOOK) and Sagimet Biosciences, Inc. Class A (SGMT)
No Data
No Data